Export presentation Axolight 05/2012 | www.soliance.com
AXOLIGHT
Innovative lightening active ingredient
• Ecocert approved • New mode of action in melanogenesis
Export presentation Axolight 05/2012 | www.soliance.com2
• The pigmentation of the skin
results from the presence of
eumelanin (black-brown) and
pheomelanin (yellow-orange) in
the epidermis
• Melanin is synthesized, in 4
steps, in specialised cells, the
melanocytes, which transfer
them to the keratinocytes.
Biologicalcontext
DERMISEPIDERMIS Maturation stages of melanosomes
into the melanocytes.
Export presentation Axolight 05/2012 | www.soliance.com3
AXOlight : ArabinoXylo-Oligosaccharides
Structure : Xylose chain substitued by Arabinose
Mean degree of Polymerization : 4
Structure
Export presentation Axolight 05/2012 | www.soliance.com4
Fabrication process is composed in 5 major steps :
 Raw material destarching (without solvent)
 Enzymatic hydrolyse of hemicelluloses (specific)
 Separation of arabinoxylanes
 Purification
 Standardization of the concentration
Productionprocess
Export presentation Axolight 05/2012 | www.soliance.com5
In Vitro test- Protocol
Normal human melanocytes are incubated 72 hours at 37°C, on a humid atmosphere with 5% of CO2.
Incubation is made with:
- Culture medium only
- with Kojic acid at 0,003% (positive reference)
- or with increasing concentration of Axolight
Melanin dosage is measured with a spectrophotometer at 405 nm.
Axolight inhibits melanogenesis
more efficiently than kojic acid
Axolightinhibitsthemelanogenesis
Inhibition of melanogenesis
Axolight inhibits melanogenesis with a dose effect
Export presentation Axolight 05/2012 | www.soliance.com6
In Vitro test - Protocole
Tyrosinase activity is quantified with a spectrophotometer, with L-DOPA (substrate of tyrosinase). After
the action of the tyrosinase, L-DOPA is transformed in dopachrom which is a colored compound
detectable by spectrocolorimeter at 490 nm.
Axolight inhibits melanogenesis via
tyrosinase and another pathway
Inhibitionofmelanogenesis:
tyrosinaseakeyenzyme
Even though Axolight significantly inhibits melanogenesis, it is only partially due to its inhibition of tyrosinase
indicating that it works in another metabolic pathway melanogenesis.
Inhibition of tyrosinase activity
Export presentation Axolight 05/2012 | www.soliance.com7
Melanogenesis:newdata
1. If tyrosine is at a low
concentration, TRP-1 can induce
transformation of tyrosine in
L-DOPA.
2. The augmentation of L-DOPA
quantity induce the activation of
tyrosinase.
3. TRP-1 forms a complex with
activated tyrosinase to stabilize it
and increase its activity.
References:
Human tyrosinase related protein-1
(TRP-1)
Tyrp1 and Oculocutaneous Albinism
Type 3
Human TRP-1 Has Tyrosine
Hydroxylase but no DOPA Oxidase
activity
Protein kinase C-b-mediated complex
formation
(TRP-1)
1
2
3
Export presentation Axolight 05/2012 | www.soliance.com8
Ex Vivo test - Protocol
Skin explants (33 year old Caucasian woman) were treated with different treatments during 10 days:
- Application of a cream containing 3% of Axolight every 2 days
- Irradiation by UV every day.
Number of TRP-1 positive melanocytes is measured by immunolabelling
Axolight efficiently inhibits melanogenesis via TRP-1
InhibitionofmelanogenesisviaTRP-1
With Axolight positive TRP-1 melanocytes are reduced by 88%*
TRP-1 positive melanocytes
Composition of the cream with 3% of Axolight
Ingredients %
Xyliance 4
Caprylic/capric triglycerides 12
Aqua Qsp 100
Preservative Qs
Glycerin 1
Axolight 3
Export presentation Axolight 05/2012 | www.soliance.com9
Ex Vivo test - Protocol
Lightness of the skin (L*) is measured by
chromameter
Measure of melanine is done by image analysis
Axolight inhibits melanogenesis and
prevents UV-induced coloration
Inhibitionofmelanogenesis
Inhibition of explant color
> Axolight maintains luminosity of the skin
despite UV irradiation
Visualization of melanin at D10
a. Control batch
b. Batch treated with 3% of Axolight
a b
> Axolight reduces melanin quantity by 18%*
Composition of the cream with 3% of Axolight
Ingredients %
Xyliance 4
Caprylic/capric triglycerides 12
Aqua Qsp 100
Preservatives Qs
Glycerin 1
Axolight 3
Export presentation Axolight 05/2012 | www.soliance.com10
Melanogenesis:adoubleeffect
Export presentation Axolight 05/2012 | www.soliance.com11
In Vivo test - Protocol
Efficacy of Axolight is evaluated on a panel of volunteers (22 Asian-type women, medium age of 37
years old)
Application twice a day during 56 days, on the forearm, of 1 cream with 3% of Axolight or 1 cream with
2% of arbutin.
The coloration of the skin is measured with a mexameter and a spectrocolorimeter
(A mexameter mesures melanin quantity; the lower the mexametric index is, the lighter the skin is.)
Axolight works faster than arbutin
Lighteningeffect-InVivotest
Variation of mexametric index (lightening effect)
91% of volunteers have shown a lightening effect
(vs 82% for cream with arbutin)
Axolight presents significant results from 28 days.
Variation of luminosity L* vs D0
Export presentation Axolight 05/2012 | www.soliance.com12
Biodegradability
ECOCERT
Ecocert approved
Axolight is environmentally friendly
Environment
Pourcentage de biodégradation par rapport à la DThO
Axolight is classified as
readily biodegradable
Export presentation Axolight 05/2012 | www.soliance.com13
Caracteristics
INCI Name: Water (and) Hydrolyzed wheat flour
Aspect : yellow to amber liquid
Odor: odorless
Preservative : none
Dosage : 2-3%
Cosmetic uses
Axolight is recommended in :
• lightening products
• Anti-aging products, for age spot prevention
• ECOCERT products
Cosmeticuses
APPLICATIONS BENEFITS EXEMPLES
Sun
Protection
PREVENT
Sun screen
UV Protection
Age spot
prevention
care
Day cream
Night cream
Cleansing gel
Foam
Lotion
Mask
Whitening care
LIGHTEN
Complexion
lightening
Tinted cream
nude make-up
After-sun EXTEND Cream
Export presentation Axolight 05/2012 | www.soliance.com14
• Patented and Ecocert validated
• Efficacy proved
• Double inhibition of melanogenesis
• Innovative mode of action
• Environment friendly
Put the light on your beauty!
Conclusion

More Related Content

PPTX
Liposome based protien and peptide delivery
PDF
Domain-specific analysis of collagen code
PPTX
Hetero poly saccharides mainly glycosaminoglycans
PPT
Glycoprotein by KK Sahu sir
PPTX
Animal species specific quantification of gelatin with TrustGel
PPTX
Ukicrs poster april 2016 (1)
Liposome based protien and peptide delivery
Domain-specific analysis of collagen code
Hetero poly saccharides mainly glycosaminoglycans
Glycoprotein by KK Sahu sir
Animal species specific quantification of gelatin with TrustGel
Ukicrs poster april 2016 (1)

What's hot (20)

PPTX
Ethosomes
PPT
Carbohydrate stains new
PPTX
Powerpoint_design_for_Skin_care_company
PPTX
Polysaccharides as building blocks for nanotherapeutics
PPTX
PPTX
AS-U1-2.2 carbohydrates-monosaccharides
PDF
HML200
PPTX
Dermaxin
PDF
Metabolism of drugs
PDF
Formulation and evaluation of ciclopirox using ethosomal gel
PPT
Penetration enhancers
PPT
Glycoprotein, lipoprotein, structure and function
PPTX
AS-U1-2.3 Carbohydrates-disaccharides and polysaccharides
DOCX
CHAPTER 4 RESULT AND DISSICUSION
PPTX
Disaccharides
PPT
Glycoprotein 12
PPTX
Histidine metabolism
PDF
Polysaccharides azhar 2020-1
PPTX
Polysaccharide
PPTX
Final poster_TSweeting (1)
Ethosomes
Carbohydrate stains new
Powerpoint_design_for_Skin_care_company
Polysaccharides as building blocks for nanotherapeutics
AS-U1-2.2 carbohydrates-monosaccharides
HML200
Dermaxin
Metabolism of drugs
Formulation and evaluation of ciclopirox using ethosomal gel
Penetration enhancers
Glycoprotein, lipoprotein, structure and function
AS-U1-2.3 Carbohydrates-disaccharides and polysaccharides
CHAPTER 4 RESULT AND DISSICUSION
Disaccharides
Glycoprotein 12
Histidine metabolism
Polysaccharides azhar 2020-1
Polysaccharide
Final poster_TSweeting (1)
Ad

Similar to Axolight (20)

PDF
Melan’oWhite
PDF
UTRAMIZE-B37-Liposomal Ampelopsin
PPTX
Ethosome
PDF
Transferosomes
DOC
Age reversing drugs
PPTX
Microneedle Patch for Breast Cancer.pptx
PPTX
Designing of cosmeceutical product addressing pigmentation
PPTX
Liraglutide in Diabetes
PPTX
Niosomes (TARGETTEDDRUG DELIVERY SYSTEM)
PDF
The efficacy of Isotretinoin-loaded solid lipid nanoparticles in comparison t...
PPTX
1. dr. Irma - Skin Whitening in dark skin.pptx
PPTX
Lectin-functionalized carboxymethylated kappa-carrageenan microparticles for ...
PDF
The Analysis of SunscreenActive Ingredients and Parabens in Lotions and Lip B...
PPTX
Ocular drug delivery system
PPTX
Permeation enhancer of Transdermal drug delivery system
PPTX
FORMULATION AND INVITRO EVALUATION OF COLON SPECIFIC DRUG DELIVERY SYSTEM BY ...
PDF
Niosomes
PDF
Pycnogenol For Oral Skin Care
PDF
Fc k5 presentation
PPTX
recent updates in cosmetic technology
Melan’oWhite
UTRAMIZE-B37-Liposomal Ampelopsin
Ethosome
Transferosomes
Age reversing drugs
Microneedle Patch for Breast Cancer.pptx
Designing of cosmeceutical product addressing pigmentation
Liraglutide in Diabetes
Niosomes (TARGETTEDDRUG DELIVERY SYSTEM)
The efficacy of Isotretinoin-loaded solid lipid nanoparticles in comparison t...
1. dr. Irma - Skin Whitening in dark skin.pptx
Lectin-functionalized carboxymethylated kappa-carrageenan microparticles for ...
The Analysis of SunscreenActive Ingredients and Parabens in Lotions and Lip B...
Ocular drug delivery system
Permeation enhancer of Transdermal drug delivery system
FORMULATION AND INVITRO EVALUATION OF COLON SPECIFIC DRUG DELIVERY SYSTEM BY ...
Niosomes
Pycnogenol For Oral Skin Care
Fc k5 presentation
recent updates in cosmetic technology
Ad

More from Алоха (20)

PDF
Пептиди Peptides
PDF
Vertera catalogue pages
PDF
Vertera
PDF
СРЕЩИ С БУРОВ
PDF
Invita Active ENG
PDF
Invita Active RU
PDF
Kолаген за коса Inventia - www.svoizbor
PDF
Ho’oponopono® Business Class
PDF
Inventia collagen - hashtag magazine
PDF
Natriance, simply essential, inspired by Nature™” Body Care & Face Care
PDF
Natriance brightener sheet vf
PDF
Collagen whitening cream ru
PDF
Продуктов каталог на колаген Inventia
PDF
ексфолиращ пилинг крем и колагенов блясък за устни на Inventia
PDF
Natural Collagen Inventia EN PL RU
PDF
Natural Collagen Inventia EN DE ES
PDF
грижа за косата Mannierox
PDF
8 honey nutrient functional review
PDF
Bee productsf unctional
PDF
Venom book review
Пептиди Peptides
Vertera catalogue pages
Vertera
СРЕЩИ С БУРОВ
Invita Active ENG
Invita Active RU
Kолаген за коса Inventia - www.svoizbor
Ho’oponopono® Business Class
Inventia collagen - hashtag magazine
Natriance, simply essential, inspired by Nature™” Body Care & Face Care
Natriance brightener sheet vf
Collagen whitening cream ru
Продуктов каталог на колаген Inventia
ексфолиращ пилинг крем и колагенов блясък за устни на Inventia
Natural Collagen Inventia EN PL RU
Natural Collagen Inventia EN DE ES
грижа за косата Mannierox
8 honey nutrient functional review
Bee productsf unctional
Venom book review

Recently uploaded (20)

PPTX
ROJoson PEP Talk: What / Who is a General Surgeon in the Philippines?
PDF
The Digestive System Science Educational Presentation in Dark Orange, Blue, a...
PPTX
CARDIOVASCULAR AND RENAL DRUGS.pptx for health study
PPTX
Vaccines and immunization including cold chain , Open vial policy.pptx
PPTX
ANESTHETIC CONSIDERATION IN ALCOHOLIC ASSOCIATED LIVER DISEASE.pptx
PPTX
Post Op complications in general surgery
PPTX
NRP and care of Newborn.pptx- APPT presentation about neonatal resuscitation ...
PPTX
Impression Materials in dental materials.pptx
PDF
04 dr. Rahajeng - dr.rahajeng-KOGI XIX 2025-ed1.pdf
PDF
Glaucoma Definition, Introduction, Etiology, Epidemiology, Clinical Presentat...
PDF
Lecture 8- Cornea and Sclera .pdf 5tg year
PDF
AGE(Acute Gastroenteritis)pdf. Specific.
PPTX
Hearthhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh
PPTX
HYPERSENSITIVITY REACTIONS - Pathophysiology Notes for Second Year Pharm D St...
PDF
OSCE Series Set 1 ( Questions & Answers ).pdf
PPT
nephrology MRCP - Member of Royal College of Physicians ppt
PPT
Dermatology for member of royalcollege.ppt
PPTX
NUCLEAR-MEDICINE-Copy.pptxbabaabahahahaahha
PPTX
thio and propofol mechanism and uses.pptx
PDF
OSCE SERIES ( Questions & Answers ) - Set 3.pdf
ROJoson PEP Talk: What / Who is a General Surgeon in the Philippines?
The Digestive System Science Educational Presentation in Dark Orange, Blue, a...
CARDIOVASCULAR AND RENAL DRUGS.pptx for health study
Vaccines and immunization including cold chain , Open vial policy.pptx
ANESTHETIC CONSIDERATION IN ALCOHOLIC ASSOCIATED LIVER DISEASE.pptx
Post Op complications in general surgery
NRP and care of Newborn.pptx- APPT presentation about neonatal resuscitation ...
Impression Materials in dental materials.pptx
04 dr. Rahajeng - dr.rahajeng-KOGI XIX 2025-ed1.pdf
Glaucoma Definition, Introduction, Etiology, Epidemiology, Clinical Presentat...
Lecture 8- Cornea and Sclera .pdf 5tg year
AGE(Acute Gastroenteritis)pdf. Specific.
Hearthhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh
HYPERSENSITIVITY REACTIONS - Pathophysiology Notes for Second Year Pharm D St...
OSCE Series Set 1 ( Questions & Answers ).pdf
nephrology MRCP - Member of Royal College of Physicians ppt
Dermatology for member of royalcollege.ppt
NUCLEAR-MEDICINE-Copy.pptxbabaabahahahaahha
thio and propofol mechanism and uses.pptx
OSCE SERIES ( Questions & Answers ) - Set 3.pdf

Axolight

  • 1. Export presentation Axolight 05/2012 | www.soliance.com AXOLIGHT Innovative lightening active ingredient • Ecocert approved • New mode of action in melanogenesis
  • 2. Export presentation Axolight 05/2012 | www.soliance.com2 • The pigmentation of the skin results from the presence of eumelanin (black-brown) and pheomelanin (yellow-orange) in the epidermis • Melanin is synthesized, in 4 steps, in specialised cells, the melanocytes, which transfer them to the keratinocytes. Biologicalcontext DERMISEPIDERMIS Maturation stages of melanosomes into the melanocytes.
  • 3. Export presentation Axolight 05/2012 | www.soliance.com3 AXOlight : ArabinoXylo-Oligosaccharides Structure : Xylose chain substitued by Arabinose Mean degree of Polymerization : 4 Structure
  • 4. Export presentation Axolight 05/2012 | www.soliance.com4 Fabrication process is composed in 5 major steps :  Raw material destarching (without solvent)  Enzymatic hydrolyse of hemicelluloses (specific)  Separation of arabinoxylanes  Purification  Standardization of the concentration Productionprocess
  • 5. Export presentation Axolight 05/2012 | www.soliance.com5 In Vitro test- Protocol Normal human melanocytes are incubated 72 hours at 37°C, on a humid atmosphere with 5% of CO2. Incubation is made with: - Culture medium only - with Kojic acid at 0,003% (positive reference) - or with increasing concentration of Axolight Melanin dosage is measured with a spectrophotometer at 405 nm. Axolight inhibits melanogenesis more efficiently than kojic acid Axolightinhibitsthemelanogenesis Inhibition of melanogenesis Axolight inhibits melanogenesis with a dose effect
  • 6. Export presentation Axolight 05/2012 | www.soliance.com6 In Vitro test - Protocole Tyrosinase activity is quantified with a spectrophotometer, with L-DOPA (substrate of tyrosinase). After the action of the tyrosinase, L-DOPA is transformed in dopachrom which is a colored compound detectable by spectrocolorimeter at 490 nm. Axolight inhibits melanogenesis via tyrosinase and another pathway Inhibitionofmelanogenesis: tyrosinaseakeyenzyme Even though Axolight significantly inhibits melanogenesis, it is only partially due to its inhibition of tyrosinase indicating that it works in another metabolic pathway melanogenesis. Inhibition of tyrosinase activity
  • 7. Export presentation Axolight 05/2012 | www.soliance.com7 Melanogenesis:newdata 1. If tyrosine is at a low concentration, TRP-1 can induce transformation of tyrosine in L-DOPA. 2. The augmentation of L-DOPA quantity induce the activation of tyrosinase. 3. TRP-1 forms a complex with activated tyrosinase to stabilize it and increase its activity. References: Human tyrosinase related protein-1 (TRP-1) Tyrp1 and Oculocutaneous Albinism Type 3 Human TRP-1 Has Tyrosine Hydroxylase but no DOPA Oxidase activity Protein kinase C-b-mediated complex formation (TRP-1) 1 2 3
  • 8. Export presentation Axolight 05/2012 | www.soliance.com8 Ex Vivo test - Protocol Skin explants (33 year old Caucasian woman) were treated with different treatments during 10 days: - Application of a cream containing 3% of Axolight every 2 days - Irradiation by UV every day. Number of TRP-1 positive melanocytes is measured by immunolabelling Axolight efficiently inhibits melanogenesis via TRP-1 InhibitionofmelanogenesisviaTRP-1 With Axolight positive TRP-1 melanocytes are reduced by 88%* TRP-1 positive melanocytes Composition of the cream with 3% of Axolight Ingredients % Xyliance 4 Caprylic/capric triglycerides 12 Aqua Qsp 100 Preservative Qs Glycerin 1 Axolight 3
  • 9. Export presentation Axolight 05/2012 | www.soliance.com9 Ex Vivo test - Protocol Lightness of the skin (L*) is measured by chromameter Measure of melanine is done by image analysis Axolight inhibits melanogenesis and prevents UV-induced coloration Inhibitionofmelanogenesis Inhibition of explant color > Axolight maintains luminosity of the skin despite UV irradiation Visualization of melanin at D10 a. Control batch b. Batch treated with 3% of Axolight a b > Axolight reduces melanin quantity by 18%* Composition of the cream with 3% of Axolight Ingredients % Xyliance 4 Caprylic/capric triglycerides 12 Aqua Qsp 100 Preservatives Qs Glycerin 1 Axolight 3
  • 10. Export presentation Axolight 05/2012 | www.soliance.com10 Melanogenesis:adoubleeffect
  • 11. Export presentation Axolight 05/2012 | www.soliance.com11 In Vivo test - Protocol Efficacy of Axolight is evaluated on a panel of volunteers (22 Asian-type women, medium age of 37 years old) Application twice a day during 56 days, on the forearm, of 1 cream with 3% of Axolight or 1 cream with 2% of arbutin. The coloration of the skin is measured with a mexameter and a spectrocolorimeter (A mexameter mesures melanin quantity; the lower the mexametric index is, the lighter the skin is.) Axolight works faster than arbutin Lighteningeffect-InVivotest Variation of mexametric index (lightening effect) 91% of volunteers have shown a lightening effect (vs 82% for cream with arbutin) Axolight presents significant results from 28 days. Variation of luminosity L* vs D0
  • 12. Export presentation Axolight 05/2012 | www.soliance.com12 Biodegradability ECOCERT Ecocert approved Axolight is environmentally friendly Environment Pourcentage de biodégradation par rapport à la DThO Axolight is classified as readily biodegradable
  • 13. Export presentation Axolight 05/2012 | www.soliance.com13 Caracteristics INCI Name: Water (and) Hydrolyzed wheat flour Aspect : yellow to amber liquid Odor: odorless Preservative : none Dosage : 2-3% Cosmetic uses Axolight is recommended in : • lightening products • Anti-aging products, for age spot prevention • ECOCERT products Cosmeticuses APPLICATIONS BENEFITS EXEMPLES Sun Protection PREVENT Sun screen UV Protection Age spot prevention care Day cream Night cream Cleansing gel Foam Lotion Mask Whitening care LIGHTEN Complexion lightening Tinted cream nude make-up After-sun EXTEND Cream
  • 14. Export presentation Axolight 05/2012 | www.soliance.com14 • Patented and Ecocert validated • Efficacy proved • Double inhibition of melanogenesis • Innovative mode of action • Environment friendly Put the light on your beauty! Conclusion